INCYTU
InCytu is a therapeutic device engineering company developing immunotherapeutic and tissue regeneration products to transform personalized medicine. Founded in 2007 and lead by a strong management team, the cornerstone of InCytu's transformative technology platform was developed by Prof. David Mooney at Harvard University. The Company's first products revolve around the Cellariumâ„¢ system, a family of intelligent bioresorbable materials which are formulated and programmed to manipulate the immune system or rapidly heal and regenerate damaged or diseased tissue.
INCYTU
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2007-01-01
Address:
Lincoln, Rhode Island, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
4013340400
Total Funding:
5.12 M USD
Technology used in webpage:
Nginx Energy Group Hosting NameSilo DNS
Similar Organizations
Boutique Venture Partners
Boutique Venture Partners specializes in early stage investments in healthcare and life sciences.
Current Employees Featured
Alfred Vasconcellos President and CEO @ InCytu
President and CEO
Founder
More informations about "InCytu"
InCytu - Crunchbase Company Profile & Funding
InCytu is a therapeutic device engineering company developing immunotherapeutic and tissue regeneration products to transform …See details»
InCytu - VentureRadar
InCytu, Inc. is a therapeutic device engineering company developing immunotherapeutic and tissue regeneration products to transform personalized medicine. Founded in 2007 and lead …See details»
Biopharmaceutical Company | Solutions for Unmet Medical Needs …
Incyte is a global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines..See details»
InCytu - Products, Competitors, Financials, Employees, …
InCytu is an applied biotechnology company developing cell therapy delivery devices which promote targeted tissue healing/regeneration or modulate the immune system. Per the …See details»
InCytu, Inc. - Scientist.com
InCytu, Inc. engages in developing cell therapy delivery devices which helps to harness and amplify the body’s natural regenerative processes. Cellarium platform technology …See details»
Elevator Pitch: Incytu, Inc. - Taylor & Francis Online
May 13, 2009 Financial & competing interests disclosure. The authors are employees of InCytu. The authors have no other relevant affiliations or financial involvement with any organization or …See details»
InCytu | EquityNet
InCytu is a therapeutic device engineering company developing immunotherapeutic and tissue regeneration products to transform personalized medicine. Founded in 2007 and lead by a …See details»
InCytu - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 13, 2012: Venture Round - …See details»
InCytu - Contacts, Employees, Board Members, Advisors & Alumni
Organization. InCytu . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. InCytu has 1 …See details»
Incyte Biosciences Canada | Biopharmaceutical Company | Incyte.ca
Incyte Biosciences Canada 2600 Alfred Nobel, Suite 301 Ville St. Laurent, Quebec CANADA H4S 0A4 For general inquiries and to contact Incyte Canada, please contact …See details»
Incyte - Wikipedia
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware, [2] and Morges, Switzerland. [3] The company was created in 2002 …See details»
Global Responsibility | Incyte.com
Even as we grow our global organization, we continue to advance progress against our sustainability goals. Governance and Risk Management. Strong ethics and good governance …See details»
Global Biopharmaceutical Company | Incyte.com
Since our start in 2002 with a small number of scientists, chemists and biologists in Wilmington, Delaware, Incyte has grown into a global organization with a robust portfolio of treatments …See details»
InCytu - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. InCytu . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 4. ... The intellectual …See details»
Incyte: A Global Biopharmaceutical Company on a Mission to …
Oct 19, 2023 A: Since starting with a small team of scientists, chemists, and biologists in Wilmington, Delaware in 2002, Incyte has grown into a global organization with a robust …See details»
InCytu - Crunchbase
InCytu develops anticancer immunotherapies that use the patient's own immune system to selectively target and destroy tumor cells.See details»
Serving Patients Through Innovation | Incyte Stories
At Incyte, our passion for serving patients is what drives everything we do, and we are proud to be a global organization with in-house capabilities ranging from early discovery to manufacturing …See details»
Financial Technology (INCyTU) - Policy Briefs & Reports - EPTA …
INCyTU Note 6 Financial Technology; FinTech (Financial Technology) is the union of digital technologies and financial services. It offers a variety of financial services to individuals, …See details»
Dermatology Research: Immune-Mediated Dermatologic …
Our research and development efforts in dermatology are initially focused on leveraging our knowledge of the JAK-STAT pathway. We are exploring the potential of JAK inhibition for a …See details»
Our Global Responsibility: By the Numbers | Incyte Stories
At Incyte, every step we take in our pursuit to find solutions for patients with critical unmet needs is anchored by our steadfast commitment to our five Global Responsibility pillars: Patients and …See details»